Literature DB >> 7611594

Human granulocytic ehrlichiosis in Massachusetts.

S R Telford1, T J Lepore, P Snow, C K Warner, J E Dawson.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7611594     DOI： 10.7326/0003-4819-123-4-199508150-00006

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  23 in total

1.  Survival of the human granulocytic ehrlichiosis agent under refrigeration conditions.

Authors:  F Kalantarpour; I Chowdhury; G P Wormser; M E Aguero-Rosenfeld
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Serology of culture-confirmed cases of human granulocytic ehrlichiosis.

Authors:  M E Aguero-Rosenfeld; F Kalantarpour; M Baluch; H W Horowitz; D F McKenna; J T Raffalli; T c Hsieh; J Wu; J S Dumler; G P Wormser
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Polymorphism and transcription at the p44-1/p44-18 genomic locus in Anaplasma phagocytophilum strains from diverse geographic regions.

Authors:  Quan Lin; Yasuko Rikihisa; Robert F Massung; Zerai Woldehiwet; Richard C Falco
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

4.  Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle.

Authors:  S R Telford; J E Dawson; P Katavolos; C K Warner; C P Kolbert; D H Persing
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

5.  Immunoserologic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents of Wisconsin and Minnesota.

Authors:  P D Mitchell; K D Reed; J M Hofkes
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

6.  Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts.

Authors:  Ana A Weil; Elinor L Baron; Catherine M Brown; Mark S Drapkin
Journal:  Mayo Clin Proc       Date:  2012-03       Impact factor: 7.616

7.  Absence of tumor necrosis factor alpha, interleukin-6 (IL-6), and granulocyte-macrophage colony-stimulating factor expression but presence of IL-1beta, IL-8, and IL-10 expression in human monocytes exposed to viable or killed Ehrlichia chaffeensis.

Authors:  E H Lee; Y Rikihisa
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

8.  Equine granulocytic ehrlichiosis in Connecticut caused by an agent resembling the human granulocytotropic ehrlichia.

Authors:  J E Madigan; J E Barlough; J S Dumler; N S Schankman; E DeRock
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

9.  c-Jun NH2-terminal kinase 2 inhibits gamma interferon production during Anaplasma phagocytophilum infection.

Authors:  Joao H F Pedra; Jochen Mattner; Jian Tao; Steven M Kerfoot; Roger J Davis; Richard A Flavell; Philip W Askenase; Zhinan Yin; Erol Fikrig
Journal:  Infect Immun       Date:  2007-11-12       Impact factor: 3.441

10.  Serologic evidence of a natural infection of white-tailed deer with the agent of human granulocytic ehrlichiosis in Wisconsin and Maryland.

Authors:  J J Walls; K M Asanovich; J S Bakken; J S Dumler
Journal:  Clin Diagn Lab Immunol       Date:  1998-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.